Evaluation of the usefulness of new (dielectric) coagulometer (R) for monitoring of the efficacy of antiplatelet medicines among patients undergone elective PCI
- Conditions
- effort angina pectoris or asymptomatic myocardial ischemia
- Registration Number
- JPRN-UMIN000022548
- Lead Sponsor
- Tokyo Medical and Dental University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Not provided
Patients who fall into any of the following criteria are excluded from participating in the study. 1. At high risks of bleeding 2. Have an experience of hypersensitivity to aspirin or prasugrel in the past 3. Currently pregnant, or possibly pregnant, or planning to be pregnant during the study 4. Had used P2Y12 inhibitor within two weeks before providing written consent 5. Have been prescribed with antiplatelets such as clopidogrel, cilostazol, sarpogrelate hydrochloride, etc. excluding aspirin 6. Currently on any anticoagulant, or planning to use an anticoagulant 7. Had joined other clinical study within the last month or currently being part of a clinical study, or planning to join other study while participating in this study 8. Other condition that the researcher thinks the participant is inappropriate to participate
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method